Wednesday 21 November 2018
Home      All news      Contact us     
foxbusiness - 1 month ago

Novartis boosts outlook, announces $2.1B Endocyte deal

The Swiss healthcare company is paying 24 dollars per share in cash for Endocyte.

Related news

Latest News
Hashtags:   

Novartis

 | 

boosts

 | 

outlook

 | 

announces

 | 

Endocyte

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources